Spinal Muscular Atrophy

• FDA approval · 2017-11-21
  FDA Approved: SPINRAZA — Supplemental Application (Biogen Inc.)

  FDA approved a supplemental application for Spinraza (nusinersen) filed by Biogen, updating the drug's regulatory status.

• EMA approval · 2017-04-21
  First medicine for spinal muscular atrophy

  EMA announces the first medicine approved for spinal muscular atrophy, marking a milestone in treatment for this disease in Europe.

• FDA approval · 2016-12-23
  FDA Approved: SPINRAZA — Original Application (Biogen Inc.)

  FDA approved Spinraza (nusinersen) from Biogen in its original application for spinal muscular atrophy.